BR9810095A - Dispositivos para distribuição de droga e métodospara tratamento de infecções virais e microbianase de sìndromes de emaciação - Google Patents

Dispositivos para distribuição de droga e métodospara tratamento de infecções virais e microbianase de sìndromes de emaciação

Info

Publication number
BR9810095A
BR9810095A BR9810095-5A BR9810095A BR9810095A BR 9810095 A BR9810095 A BR 9810095A BR 9810095 A BR9810095 A BR 9810095A BR 9810095 A BR9810095 A BR 9810095A
Authority
BR
Brazil
Prior art keywords
infections
methods
drug delivery
treating viral
delivery devices
Prior art date
Application number
BR9810095-5A
Other languages
English (en)
Inventor
Michelle Olga Patricia Visser
Original Assignee
Cryopreservation Tech Cc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Cryopreservation Tech Cc filed Critical Cryopreservation Tech Cc
Publication of BR9810095A publication Critical patent/BR9810095A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"DISPOSITIVOS PARA DISTRIBUIçãO DE DROGA EMéTODOS PARA TRATAMENTO DE INFECçõES VIRAIS EMICROBIANAS E DE SìNDROMES DE EMACIAçãO". Novosdispositivos para distribuição de droga, métodos e composiçõesterapêuticas são descritos para o tratamento de infecções virais emicrobianas e síndromes de emaciação em um animal, incluindoum paciente humano. De acordo com a invenção, um compostopolar, tal como dimetilformamida ou dimetilssulfóxido, é administradoa um paciente que necessite de tratamento, preferivelmente por viatransdérmica. A invenção provê, ainda, uma vacina preparada deanticorpos colhidos do corpo de um paciente tratado de acordocom o método da invenção para uma infecção viral.
BR9810095-5A 1997-06-13 1998-06-09 Dispositivos para distribuição de droga e métodospara tratamento de infecções virais e microbianase de sìndromes de emaciação BR9810095A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
PCT/US1998/011956 WO1998056325A1 (en) 1997-06-13 1998-06-09 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes

Publications (1)

Publication Number Publication Date
BR9810095A true BR9810095A (pt) 2001-11-13

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810095-5A BR9810095A (pt) 1997-06-13 1998-06-09 Dispositivos para distribuição de droga e métodospara tratamento de infecções virais e microbianase de sìndromes de emaciação

Country Status (34)

Country Link
EP (1) EP1011567A1 (pt)
JP (1) JP4531141B2 (pt)
KR (1) KR20010013709A (pt)
CN (1) CN1260703A (pt)
AP (1) AP1629A (pt)
AR (1) AR012970A1 (pt)
AU (1) AU7831598A (pt)
BG (1) BG103997A (pt)
BR (1) BR9810095A (pt)
CA (1) CA2295176A1 (pt)
CZ (1) CZ298510B6 (pt)
EA (1) EA200000011A1 (pt)
EE (1) EE9900562A (pt)
ES (1) ES2161187B1 (pt)
FI (1) FI19992648A (pt)
GB (1) GB2341319B (pt)
HU (1) HUP0003034A2 (pt)
ID (1) ID23516A (pt)
IL (2) IL133396A0 (pt)
IS (1) IS5289A (pt)
LT (1) LT4714B (pt)
LV (1) LV12490B (pt)
NO (1) NO996117L (pt)
NZ (1) NZ501669A (pt)
OA (1) OA11307A (pt)
PL (1) PL196256B1 (pt)
RO (1) RO121252B1 (pt)
SI (1) SI20191A (pt)
SK (1) SK172299A3 (pt)
TN (1) TNSN98086A1 (pt)
TR (1) TR200000540T2 (pt)
WO (1) WO1998056325A1 (pt)
YU (1) YU66099A (pt)
ZA (1) ZA984649B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2006003648A0 (en) * 2003-12-05 2006-06-30 Namibia Medical Invest Pty Ltd Patch

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
WO1993016992A1 (en) * 1992-02-20 1993-09-02 Merrell Dow Pharmaceuticals Inc. Sulfonic acid derivatives in the treatment of viral diseases
EA001957B1 (ru) * 1995-12-15 2001-10-22 Вироден Фармасьютикал Холдингс (Проприетэри) Лимитед КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ СПИДа

Also Published As

Publication number Publication date
LT4714B (lt) 2000-10-25
ES2161187A1 (es) 2001-11-16
AP9901708A0 (en) 1999-12-31
IS5289A (is) 1999-12-08
CN1260703A (zh) 2000-07-19
OA11307A (en) 2003-10-24
RO121252B1 (ro) 2007-02-28
GB2341319B (en) 2002-02-27
JP2002511862A (ja) 2002-04-16
HUP0003034A2 (hu) 2000-12-28
JP4531141B2 (ja) 2010-08-25
TNSN98086A1 (fr) 2005-03-15
EA200000011A1 (ru) 2000-08-28
EP1011567A4 (en) 2000-06-28
ES2161187B1 (es) 2003-08-16
PL338439A1 (en) 2000-11-06
WO1998056325A1 (en) 1998-12-17
IL133396A0 (en) 2001-04-30
LT99148A (en) 2000-07-25
PL196256B1 (pl) 2007-12-31
KR20010013709A (ko) 2001-02-26
YU66099A (sh) 2002-10-18
ZA984649B (en) 1999-12-17
AU7831598A (en) 1998-12-30
NO996117D0 (no) 1999-12-10
AR012970A1 (es) 2000-11-22
SI20191A (sl) 2000-10-31
BG103997A (en) 2001-07-31
TR200000540T2 (tr) 2000-09-21
SK172299A3 (en) 2000-09-12
IL133396A (en) 2006-10-05
GB9929189D0 (en) 2000-02-02
EP1011567A1 (en) 2000-06-28
NO996117L (no) 2000-02-11
GB2341319A (en) 2000-03-15
CZ298510B6 (cs) 2007-10-24
LV12490A (en) 2000-06-20
LV12490B (en) 2000-12-20
CA2295176A1 (en) 1998-12-17
EE9900562A (et) 2000-06-15
FI19992648A (fi) 2000-02-03
ID23516A (id) 2000-04-27
AP1629A (en) 2006-07-11
NZ501669A (en) 2001-09-28
CZ9904473A3 (cs) 2001-03-14

Similar Documents

Publication Publication Date Title
BR0209658A (pt) Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina
DK1151009T3 (da) Antimikrobielt/endotoksin-neutraliserende polypeptid
BR0109446A (pt) Medicamento para a aplicação intracorpórea, uso de um xanteno halogenado, composição farmacêutica, e, método de tratamento
BR0316685A (pt) Composições e métodos para a administração aperfeiçoada por via mucosal de peptìdeos fixadores ao receptor de y2 e métodos para tratar e prevenir a obesidade
IL139231A0 (en) Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract
PT698108E (pt) Vectores adenovirais de origem animal e utilizacao em terapia genica
MY117892A (en) Therapeutic compounds
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
BR0316157A (pt) Derivados de 4-amino-5-fenil-7-ciclohexil-pirrolo[2,3-d]pirimidina
DE60112777D1 (de) Beschichtete medizinische geräte und verfahren zur sterilisation
ATE399562T1 (de) Verwendung von milchserum-apoproteinen bei der prophylaxe oder behandlung von mikrobiellen oder virusinfektionen
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
BRPI0407178A (pt) Composição farmacêutica osteogênica
TR199801614T2 (xx) Peptit t�revleri
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
MX9805441A (es) Compuestos terapeuticos.
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
BR0315609A (pt) Método de tratar, prevenir, modificar ou controlar dor e composição farmacêutica
ATE454139T1 (de) Arzneimittel mit shikonin als wirkstoff
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
BR9810095A (pt) Dispositivos para distribuição de droga e métodospara tratamento de infecções virais e microbianase de sìndromes de emaciação
ATE185274T1 (de) Therapeutisches mittel gegen drohenden abortus
ES2233101T3 (es) Dosis unitaria de fgf-2 angiogenicamente efectiva y su utilizacion.
RU95110774A (ru) Олигонуклеотиды, терапевтические композиции, применение композиций
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 9/00, A61K 31/10, A61K 31/13, A61K 13/16, A61F 13/00, A61K 31/164, A61K 31/198, A61K 31/44, A61K 31/4412, A61K 31/5375, A61K 39/395, A61P 31/12, A61P 31/18, A61P 43/00

Ipc: A61K 9/00 (2008.04), A61K 31/10 (2008.04), A61K 31

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.